Cancer charities have condemned a decision not to licence a drug being trialled in our region which extends the life of women suffering the advanced stages of breast cancer.
The National Institute for Clinical Excellence - or NICE - says the drug "Perjeeta" isn't cost effective.
Perjeeta is currently being tested on women through the Christie Hospital in Manchester - but it isn't routinely available on the NHS.
Cancer charities and women taking the drug want NICE to reconsider .
Ashley Derricott reports.
More top news
The brother of Caroline Aherne has talked publicly about his sister for the first time since her death.
The floor of a hospital waiting room was so dirty a young mum managed to write ‘clean me now’ on it.
A cancer charity is calling for more support for so-called 'Sandwich Carers'.